Yousuf A. Gaffar, M.D

Physician - Hematology and Medical Oncology

Yousuf A. Gaffar, M.D, is a dedicated and experienced physician specializing in hematology and medical oncology, with nearly 20 years of experience in clinical practice and cancer research. Throughout his career, Dr. Gaffar has focused on providing the highest level of patient care, combining the latest advancements in oncology with a deep commitment to understanding and addressing the unique needs of each individual. His approach to medicine is built on compassion, communication, and a thorough understanding of patients' challenges when battling cancer.

Dr. Gaffar’s medical journey began at Saba University School of Medicine, where he earned his Doctor of Medicine (M.D.) degree. After completing his medical education, he pursued a residency at Rutgers-Robert Wood Johnson Medical School, where he served as Chief Resident. During this time, Dr. Gaffar developed a keen interest in oncology, motivating him to pursue a fellowship in Medical Oncology and Hematology at the USF-Moffitt Cancer Center. During his fellowship, he focused on Genitourinary (GU) and Senior Adult oncology, where he contributed to research that helped shape his expertise and approach to cancer care.

As a board-certified oncologist and hematologist, Dr. Gaffar is committed to staying at the forefront of the rapidly evolving field of oncology. He continuously updates his knowledge and integrates the latest medical advancements into his practice, ensuring that his patients receive the most effective therapies. His dedication to ongoing education ensures that he provides the highest standard of care while adapting to new treatments and research findings.

In addition to his clinical expertise, Yousuf Gaffar has significantly contributed to cancer research. He has led several important research programs and clinical trials to improve cancer therapies and patient care. These initiatives have garnered national recognition, and his leadership has been instrumental in making cutting-edge treatments available to patients in community oncology settings. Dr. Gaffar’s work has earned numerous awards from organizations such as US Oncology, acknowledging his significant impact on advancing cancer care and treatment protocols.

Dr. Gaffar is the Medical Director of Medical Oncology Research for AdventHealth Rocky Mountain Region. In this role, he oversees the integration of new cancer therapies and ensures patients can access the latest clinical trials. His leadership has helped bring innovative treatments to patients much earlier than they would typically be available in non-academic settings. Through collaborations with pharmaceutical companies, research institutions, and healthcare providers, he has played a key role in expanding access to cutting-edge cancer care.

Dr. Gaffar’s expertise spans various cancers, including breast, lung, gastrointestinal (GI), genitourinary (GU), and blood cancers. He approaches each patient with empathy, carefully considering their medical history, personal goals, and preferences. Dr. Gaffar believes that a strong doctor-patient relationship is essential to effective treatment, and he works closely with his patients to develop personalized treatment plans that align with their values. By fostering open communication and continuous support, he ensures patients feel empowered and informed throughout their treatment.

Yousuf Gaffar has been recognized for his excellence in patient care and research. He has been named a “Top Doctor” in the Baltimore area multiple times, reflecting the trust and respect he has earned from both his patients and colleagues. His research has been published in leading medical journals and has contributed to developing new guidelines and treatment strategies in oncology. Dr. Gaffar is also an in-demand speaker at medical conferences, sharing his knowledge and insights on the latest advancements in cancer treatment.

Dr. Gaffar leads a fulfilling and balanced lifestyle outside of his professional life. He enjoys ballroom dancing, which provides a creative and enjoyable way to unwind. Gardening is another hobby that allows him to relax and connect with nature, providing a peaceful retreat from the demands of his profession. He is also passionate about hiking and exploring the natural beauty of Colorado, embracing the physical and mental benefits of spending time outdoors. In addition, he participates in competitive axe throwing, a sport that requires precision and focus—skills that parallel his meticulous approach to medicine.

He is deeply involved in philanthropy and community outreach. He has volunteered with the American Cancer Society to help raise awareness and support those affected by cancer. From 2005 to 2024, Dr. Gaffar served on the Baltimore Cancer Support Group board, where he helped provide emotional and practical support to cancer patients and their families. His dedication to these organizations reflects his belief that cancer care must extend beyond treatment to include education, advocacy, and emotional support for patients and their loved ones.

As Dr. Gaffar reflects on nearly 20 years of practice, he remains dedicated to advancing cancer treatment, improving patient outcomes, and offering hope to those facing cancer. His work has touched the lives of many, but he remains focused on the future, continuing to push the boundaries of cancer care through research, education, and compassionate patient care. He is currently recertifying his board certifications in medical oncology and hematology to ensure that he remains at the forefront of the latest developments in the field.

Looking ahead, Dr. Gaffar’s mission remains clear: to continue advancing cancer care, empowering patients with knowledge, and providing hope to those facing the challenges of cancer. Yousuf A. Gaffar, M.D, will continue to make a lasting impact on the field of oncology, ensuring that his patients receive the best possible medical care and the support they need to navigate the complexities of cancer. His unwavering dedication to his patients and the oncology community will continue to shape the future of cancer treatment for years to come.